Discovery calls ROI benchmarks and payback periods for healthcare and life sciences
The real ROI, CAC payback, and time-to-value ranges for discovery calls across B2B categories. Written for commercial leaders at healthtech, medtech, and life-sciences companies.
This edition is written for commercial leaders at healthtech, medtech, and life-sciences companies. In healthcare and life sciences, healthcare buyers move under regulatory constraint and reward domain-specific messaging, so the way you install discovery calls has to reflect that reality from day one.
Payback is the honest ROI question for discovery calls: how many months from first dollar spent to first dollar returned. Below are the ranges we see, split by category and starting condition.
Best-case payback for discovery calls in a category with warm demand: 60–90 days. Median: 4–6 months. Cold category with no warm inbound: 6–9 months.
The dominant driver of payback is trigger quality, not spend. Everything after discovery is downstream of what you learned in it — teams that respect this get inside the shorter range.
The binding constraint we see in healthcare and life sciences is almost always regulated-sale cycle length, not intent. Discovery calls is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.
Discovery-to-opportunity conversion is the leading indicator. If it moves inside the first six weeks, payback usually lands in the best case. If it stalls for a month, replan.
ROI compounds after payback. By month 12, well-run discovery calls functions typically produce 3–5x return on total cost of ownership.
Bad ROI has one signature: reading a script instead of running a diagnosis. Where you see broken payback, you see this pattern almost every time.
Benchmarks are useful as a sanity check, not a target. The target is the one your finance team commits to on the current-year plan; benchmarks tell you if that target is plausible.
Concretely for healthcare and life sciences: the healthcare teams that install this get past procurement instead of dying in it. That is the reason it is worth installing discovery calls properly rather than half-heartedly across three vendors.
Frequently asked questions
Sales · healthcare — answered
- Does discovery calls work for healthcare and life sciences?
- Yes — provided it is aimed at regulated-sale cycle length, not intent rather than a generic growth number. The healthcare teams that install this get past procurement instead of dying in it.
- What is a good payback period for discovery calls?
- Best case 60–90 days; median 4–6 months; cold-category 6–9 months.
- What drives discovery calls ROI more than anything else?
- Trigger quality. Spend and headcount matter less.
- When does discovery calls start to compound?
- Typically after month six, once the operating rhythm is muscle memory.
- What is the leading indicator of poor ROI?
- Discovery-to-opportunity conversion stalling for four consecutive weeks.
- What is the healthcare specific pitfall with discovery calls?
- Running the generic playbook without adapting to healthcare buyers move under regulatory constraint and reward domain-specific messaging. The install has to be vertical-first.
Growth Broker editorial
Filed under sales · healthcare